Microglia P2Y6 receptors mediate nitric oxide release and astrocyte apoptosis

Journal of Neuroinflammation

Volumn 11, Issue 1, 2014, Pages

  Quintas, Clara ^a   Pinho, Diana ^a   Pereira, Clara ^a,b   Saraiva, Lucília ^a   Gonçalves, Jorge ^a   Queiroz, Glória ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Apoptosis; Astroglial proliferation; lipopolysaccharide; Microglia; Nitric oxide; P2Y6 receptors; Uracil nucleotides

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 3 (2 OXO 2 PHENYLETHYL)URIDINE 5' DIPHOSPHATE SODIUM; 3 [8 [(DIMETHYLAMINO)METHYL] 6,7,8,9 TETRAHYDROPYRIDO[1,2 A]INDOL 10 YL] 4 (1 METHYL 1H INDOL 3 YL) 1H PYRROLE 2,5 DIONE; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MRS 2578; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PURINERGIC P2Y6 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PYRIMIDINE NUCLEOTIDE; UNCLASSIFIED DRUG; URIDINE DERIVATIVE; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE; ENZYME INHIBITOR; GLIAL FIBRILLARY ACIDIC PROTEIN; PURINERGIC P2 RECEPTOR; THYMIDINE; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL DEATH; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; ENZYME ASSAY; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; INFLAMMATION; MICROGLIA; MOLECULAR MECHANICS; NICK END LABELING; NONHUMAN; NUCLEOTIDE METABOLISM; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; STAINING; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CELL CYCLE; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; NEWBORN; PHYSIOLOGY; RAT; TIME; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; ASTROCYTES; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; LIPOPOLYSACCHARIDES; MICROGLIA; NITRIC OXIDE; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P2; THYMIDINE; TIME FACTORS; TRITIUM; URACIL NUCLEOTIDES;

EID: 84910037446     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/s12974-014-0141-3     Document Type: Article

References (45)

1. Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol 2010, 119:7-35. 10.1007/s00401-009-0619-8, 20012068.
2. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007, 10:1387-1394. 10.1038/nn1997, 17965659.
3. Pekny M, Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005, 50:427-434. 10.1002/glia.20207, 15846805.
4. Cavanagh JB. The proliferation of astrocytes around a needle wound in the rat brain. J Anat 1970, 106:471-487. 4912665.
5. Buffo A, Rolando C, Ceruti S. Astrocytes in the damaged brain: molecular and cellular insights into their reactive response and healing potential. Biochem Pharmacol 2010, 79:77-89. 10.1016/j.bcp.2009.09.014, 19765548.
6. Zhang D, Hu X, Qian L, O'Callaghan JP, Hong JS. Astrogliosis in CNS pathologies: is there a role for microglia?. Mol Neurobiol 2010, 41:232-241. 10.1007/s12035-010-8098-4, 20148316.
7. Hanisch UK. Microglia as a source and target of cytokines. Glia 2002, 40:140-155. 10.1002/glia.10161, 12379902.
8. Saijo K, Glass CK. Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 2011, 11:775-787. 10.1038/nri3086, 22025055.
9. Cacci E, Ajmone-Cat MA, Anelli T, Biagioni S, Minghetti L. In vitro neuronal and glial differentiation from embryonic or adult neural precursor cells are differently affected by chronic or acute activation of microglia. Glia 2008, 56:412-425. 10.1002/glia.20616, 18186084.
10. Ajmone-Cat MA, Mancini M, De Simone R, Cilli P, Minghetti L. Microglial polarization and plasticity: evidence from organotypic hippocampal slice cultures. Glia 2013, 61:1698-1711. 10.1002/glia.22550, 23918452.
11. Davies SJ, Fitch MT, Memberg SP, Hall AK, Raisman G, Silver J. Regeneration of adult axons in white matter tracts of the central nervous system. Nature 1997, 390:680-683. 9414159.
12. Franke H, Verkhratsky A, Burnstock G, Illes P. Pathophysiology of astroglial purinergic signalling. Purinergic Signal 2012, 8:629-657. 10.1007/s11302-012-9300-0, 22544529.
13. Sperlagh B, Illes P. Purinergic modulation of microglial cell activation. Purinergic Signal 2007, 3:117-127. 10.1007/s11302-006-9043-x, 18404425.
14. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 2006, 58:281-341. 10.1124/pr.58.3.3, 16968944.
15. Lecca D, Ceruti S. Uracil nucleotides: from metabolic intermediates to neuroprotection and neuroinflammation. Biochem Pharmacol 2008, 75:1869-1881. 10.1016/j.bcp.2007.12.009, 18261711.
16. Koizumi S, Shigemoto-Mogami Y, Nasu-Tada K, Shinozaki Y, Ohsawa K, Tsuda M, Joshi BV, Jacobson KA, Kohsaka S, Inoue K. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 2007, 446:1091-1095. 10.1038/nature05704, 17410128.
17. Wang M, Kong Q, Gonzalez FA, Sun G, Erb L, Seye C, Weisman GA. P2Y nucleotide receptor interaction with alpha integrin mediates astrocyte migration. J Neurochem 2005, 95:630-640. 10.1111/j.1471-4159.2005.03408.x, 16135088.
18. Queiroz G, Gebicke-Haerter PJ, Schobert A, Starke K, von Kugelgen I. Release of ATP from cultured rat astrocytes elicited by glutamate receptor activation. Neuroscience 1997, 78:1203-1208. 10.1016/S0306-4522(96)00637-9, 9174086.
19. Queiroz G, Meyer DK, Meyer A, Starke K, von Kugelgen I. A study of the mechanism of the release of ATP from rat cortical astroglial cells evoked by activation of glutamate receptors. Neuroscience 1999, 91:1171-1181. 10.1016/S0306-4522(98)00644-7, 10391492.
20. Quintas C, Fraga S, Goncalves J, Queiroz G. Opposite modulation of astroglial proliferation by adenosine 5'-O-(2-thio)-diphosphate and 2-methylthioadenosine-5'-diphosphate: mechanisms involved. Neuroscience 2011, 182:32-42. 10.1016/j.neuroscience.2011.03.009, 21419195.
21. Cunha RA, Sebastiao AM, Ribeiro JA. Inhibition by ATP of hippocampal synaptic transmission requires localized extracellular catabolism by ecto-nucleotidases into adenosine and channeling to adenosine A1 receptors. J Neurosci 1998, 18:1987-1995. 9482785.
22. Quintas C, Fraga S, Goncalves J, Queiroz G. P2Y receptors on astrocytes and microglia mediate opposite effects in astroglial proliferation. Purinergic Signal 2011, 7:251-263. 10.1007/s11302-011-9235-x, 21559785.
23. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. Physiology of microglia. Physiol Rev 2011, 91:461-553. 10.1152/physrev.00011.2010, 21527731.
24. Iravani MM, Leung CC, Sadeghian M, Haddon CO, Rose S, Jenner P. The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation. Eur J Neurosci 2005, 22:317-330. 10.1111/j.1460-9568.2005.04220.x, 16045485.
25. Possel H, Noack H, Putzke J, Wolf G, Sies H. Selective upregulation of inducible nitric oxide synthase (iNOS) by lipopolysaccharide (LPS) and cytokines in microglia: in vitro and in vivo studies. Glia 2000, 32:51-59. 10.1002/1098-1136(200010)32:1<51::AID-GLIA50>3.0.CO;2-4, 10975910.
26. Bruno CJ, Greco TM, Ischiropoulos H. Nitric oxide counteracts the hyperoxia-induced proliferation and proinflammatory responses of mouse astrocytes. Free Radic Biol Med 2011, 51:474-479. 10.1016/j.freeradbiomed.2011.04.041, 21605665.
27. Ransohoff RM, Brown MA. Innate immunity in the central nervous system. J Clin Invest 2012, 122:1164-1171. 10.1172/JCI58644, 22466658.
28. Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, Volpe JJ, Vartanian T. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A 2003, 100:8514-8519. 10.1073/pnas.1432609100, 12824464.
29. El-Tayeb A, Qi A, Muller CE. Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors. J Med Chem 2006, 49:7076-7087. 10.1021/jm060848j, 17125260.
30. Abbracchio MP, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Miras-Portugal MT, King BF, Gachet C, Jacobson KA, Weisman GA, Burnstock G. Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci 2003, 24:52-55. 10.1016/S0165-6147(02)00038-X, 12559763.
31. Mamedova LK, Joshi BV, Gao ZG, von Kugelgen I, Jacobson KA. Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors. Biochem Pharmacol 2004, 67:1763-1770. 10.1016/j.bcp.2004.01.011, 15081875.
32. von Kugelgen I. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 2006, 110:415-432. 10.1016/j.pharmthera.2005.08.014.
33. Braun N, Sevigny J, Robson SC, Enjyoji K, Guckelberger O, Hammer K, Di Virgilio F, Zimmermann H. Assignment of ecto-nucleoside triphosphate diphosphohydrolase-1/cd39 expression to microglia and vasculature of the brain. Eur J Neurosci 2000, 12:4357-4366. 11122346.
34. Wink MR, Braganhol E, Tamajusuku AS, Lenz G, Zerbini LF, Libermann TA, Sevigny J, Battastini AM, Robson SC. Nucleoside triphosphate diphosphohydrolase-2 (NTPDase2/CD39L1) is the dominant ectonucleotidase expressed by rat astrocytes. Neuroscience 2006, 138:421-432. 10.1016/j.neuroscience.2005.11.039, 16414200.
35. Brisevac D, Bajic A, Bjelobaba I, Milosevic M, Stojiljkovic M, Beyer C, Clarner T, Kipp M, Nedeljkovic N. Expression of ecto-nucleoside triphosphate diphosphohydrolase1-3 (NTPDase1-3) by cortical astrocytes after exposure to pro-inflammatory factors in vitro. J Mol Neurosci 2013, 51:871-879. 10.1007/s12031-013-0088-3, 23990338.
36. Kukulski F, Levesque SA, Lavoie EG, Lecka J, Bigonnesse F, Knowles AF, Robson SC, Kirley TL, Sevigny J. Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8. Purinergic Signal 2005, 1:193-204. 10.1007/s11302-005-6217-x, 18404504.
37. Yu W, Hill WG. Lack of specificity shown by P2Y6 receptor antibodies. Naunyn Schmiedebergs Arch Pharmacol 2013, 386:885-891. 10.1007/s00210-013-0894-8, 23793102.
38. Bianco F, Fumagalli M, Pravettoni E, D'Ambrosi N, Volonte C, Matteoli M, Abbracchio MP, Verderio C. Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia. Brain Res Brain Res Rev 2005, 48:144-156. 10.1016/j.brainresrev.2004.12.004, 15850653.
39. Wen J, Ribeiro R, Zhang Y. Specific PKC isoforms regulate LPS-stimulated iNOS induction in murine microglial cells. J Neuroinflammation 2011, 8:38. 10.1186/1742-2094-8-38, 21510893.
40. Saura J, Angulo E, Ejarque A, Casado V, Tusell JM, Moratalla R, Chen JF, Schwarzschild MA, Lluis C, Franco R, Serratosa J. Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia. J Neurochem 2005, 95:919-929. 10.1111/j.1471-4159.2005.03395.x, 16092928.
41. Lipton SA. Neuronal protection and destruction by NO. Cell Death Differ 1999, 6:943-951. 10.1038/sj.cdd.4400580, 10556970.
42. Villalobo A. Nitric oxide and cell proliferation. FEBS J 2006, 273:2329-2344. 10.1111/j.1742-4658.2006.05250.x, 16704409.
43. Gebicke-Haerter PJ, Bauer J, Schobert A, Northoff H. Lipopolysaccharide-free conditions in primary astrocyte cultures allow growth and isolation of microglial cells. J Neurosci 1989, 9:183-194. 2643682.
44. van Kralingen C, Kho DT, Costa J, Angel CE, Graham ES. Exposure to inflammatory cytokines IL-1beta and TNFalpha induces compromise and death of astrocytes; implications for chronic neuroinflammation. PLoS One 2013, 8:e84269. 10.1371/journal.pone.0084269, 24367648.
45. Oberheim NA, Goldman SA, Nedergaard M. Heterogeneity of Astrocytic Form and Function. Methods Mol Biol 2012, 814:23-45. 10.1007/978-1-61779-452-0_3, 22144298.